Sabitlenmiş Tweet

Thank you for this @ax1vc for this opportunity wish me luck! 🍀 🫶🏻💙
For me one of the biopharma theme I wish investors tracked more clearly is the growing role of AI in drug discovery, especially companies combining biotech with machine learning. And also about catalysts like faster clinical trial design, predictive diagnostics, and personalized medicine that could reshape the industry, but i think many investors still underestimate how impactful this shift and may become over the next few years.
Question: Do you think the future of biopharma investing will favor investors who understand the science deeply, or investors who have the best AI tools to interpret and contextualize the data faster?



English








